HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katarzyna Bednarska-Szczepaniak Selected Research

1- butyl- 8- (3- noradamantyl)- 3- (3- hydroxypropyl)xanthine

1/2019Adenosine Analogues as Opposite Modulators of the Cisplatin Resistance of Ovarian Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katarzyna Bednarska-Szczepaniak Research Topics

Disease

2Necrosis
07/2021 - 01/2019
2Neoplasms (Cancer)
07/2021 - 01/2019
2Ovarian Neoplasms (Ovarian Cancer)
07/2021 - 01/2019
1Carcinoma (Carcinomatosis)
07/2021

Drug/Important Bio-Agent (IBA)

2Cisplatin (Platino)FDA LinkGeneric
07/2021 - 01/2019
2Adenosine (Adenocard)FDA LinkGeneric
07/2021 - 01/2019
1ChromiumIBA
07/2021
1CobaltIBA
07/2021
1AntimetabolitesIBA
07/2021
1IronIBA
07/2021
1NucleosidesIBA
07/2021
1PlatinumIBA
07/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2021
1Platinum Compounds (Compounds, Platinum)IBA
07/2021
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2019
11- butyl- 8- (3- noradamantyl)- 3- (3- hydroxypropyl)xanthineIBA
01/2019
1ZM 241385 (ZM241385)IBA
01/2019

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2019